12:00 AM
May 28, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Oleylphosphocholine regulatory update

The European Commission granted Orphan Drug designation for Dafra's oleylphosphocholine to treat leishmaniasis. Dafra...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >